Annual vaccination with BNT162b2 in Germany can avoid substantial clinical and economic burden of COVID-19 disease
COVID-19 imposes a substantial clinical and economic burden on the German population, which could be mitigated with an expanded COVID-19 vaccination program. Further research into Long/Post COVID is needed. Our study presents considerations highlighting the value of broad vaccination especially for working adults.
Authors
- O. Witzke
- Stefan Riebel
- Afschin Gandjour
- A Schmetz (ORCID: https://orcid.org/0000-0001-6436-9382)
- Jingyan Yang
- Sam Greenall
- Amy Barber
- Julie Roiz
- Edward Church
Institutions
- Pfizer (United States) (US)
- BioNTech (Germany) (DE)
- University of Duisburg-Essen (DE)
- Frankfurt School of Finance & Management (DE)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-12-27
- DOI
- https://doi.org/10.1080/13696998.2025.2604970
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40